XENOS BIO LIMITED
Significant control: Alexander James Sheppard (25–50%), Mona Kab Omir (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Xenos Bio Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Xenos Bio Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
XENOS BIO LIMITED is an active private limited company (company number 14568344) incorporated on 3 January 2023, registered in Canterbury. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 January 2025, showing net assets of −£164k and cash of £164k, with 2 employees on average. Net assets fell 5454467% on the prior period (−£3).
By net assets it sits in the bottom quarter of 59 comparable companies in Kent (median £2,535, upper quartile £84k).
Ownership and control
- Mr Alexander James Sheppard
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Mona Kab Omir
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 3 January 20233 yrs ago
- Next accounts due
- 31 October 2026in 7 days
- Confirmation statement due
- 17 January 2027in 85 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2025 | −£164k | £164k | £14k | £347k | — | — | 2 |
| 31 January 2024 | −£3 | £10 | — | £13 | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-163,637 at 31 January 2025
- Net assets down 25% or more on the prior period-5454466.7% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.51
- Cash at bank of £50,000 or moreCash £164,166
- Incorporated two to five years agoIncorporated 3 January 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 85 days
- Next accounts duein 7 days
- Accounts period endNet liabilities £164k · small accounts
- Accounts period endNet liabilities £3 · small accounts
- Incorporated
Similar companies in Kent
- RAPID DISCOVERY LIMITEDSandwich · inc. Dec 2022
- DLOC BIOSYSTEMS LTDSandwich · inc. Feb 2023
- RS & RS SCIENTIFIC LTDSandwich · inc. Mar 2023
- ATEDA THERAPEUTICS LIMITEDChatham Maritime · inc. Sept 2023
- ONTRACK THERAPEUTICS LTDSevenoaks · inc. Dec 2021
- DISCOVERY SCALE LTDSandwich · inc. Feb 2024
All companies incorporated on 3 January 2023 · in Jan 2023.
Reminders for XENOS BIO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.